SCHEMBL18209554

SCHEMBL18209554

COC(=O)c1ccc2c(c1)NC(=O)C2=C(O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.47
TSHR P16473 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
ROCK2 O75116 1/20 0.45
CSF1R P07333 1/20 0.45
KDR P35968 1/20 0.45
FLT3 P36888 1/20 0.45
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
CDK5 Q00535 1/20 0.45
ROCK1 Q13464 1/20 0.45
SLK Q9H2G2 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.45
PDPK1 O15530 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2277337 0.88 ALDH1A1 (0.48) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL15783957 0.88 ALDH1A1 (0.48) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL29846133 0.88 ALDH1A1 (0.48) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL29400313 0.88 ALDH1A1 (0.48) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL1361818 0.88 ALDH1A1 (0.48) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL21704257 0.87 ALDH1A1 (0.47) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL30292809 0.87 ALDH1A1 (0.47) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL28421553 0.85 TDP1 (0.43) ALOX5TSHRALDH1A1LMNAROCK2
SCHEMBL2568951 0.85 TTR (0.46) ALOX5ALDH1A1LMNAPDPK1TDP1
SCHEMBL2568947 0.85 TTR (0.46) ALOX5ALDH1A1LMNAPDPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113354599-B Preparation method of nintedanib key intermediate 长沙康鹏医药有限公司 2021-10-26 CN disclosed
CN-113354599-A Preparation method of nintedanib key intermediate 长沙康鹏医药有限公司 2021-09-07 CN disclosed
WO-2016178064-A1 POLYMORPH OF NINTEDANIB ETHANESULPHONATE, PROCESSES AND INTERMEDIATES THEREOF SUVEN LIFE SCIENCES LIMITED (IN) 2016-11-10 WO disclosed